Thermo Fisher ScientificTMOEarnings & Financial Report
Thermo Fisher Scientific Inc. is an American life science and clinical research company. It is a global supplier of analytical instruments, clinical development solutions, specialty diagnostics, laboratory, pharmaceutical and biotechnology services. Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006.
TMO Q3 2025 Key Financial Metrics
营收
$11.1B
毛利润
N/A
营业利润
$1.9B
净利润
$1.6B
毛利率
N/A
营业利润率
17.5%
净利率
14.5%
同比增长
4.9%
EPS
$4.27
资金流向
Thermo Fisher Scientific Q3 2025 Financial Summary
Thermo Fisher Scientific reported revenue of $11.1B for Q3 2025, with a net profit of $1.6B (14.5% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $11.1B |
|---|---|
| Net Profit | $1.6B |
| Gross Margin | N/A |
| Operating Margin | 17.5% |
| Report Period | Q3 2025 |
Thermo Fisher Scientific Annual Revenue by Year
Thermo Fisher Scientific annual revenue history includes year-by-year totals (for example, 2024 revenue was $42.9B).
| Year | Annual Revenue |
|---|---|
| 2024 | $42.9B |
| 2023 | $43.0B |
| 2022 | $45.3B |
利润表
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| 营收 | $10.89B | $10.35B | $10.54B | $10.60B | $11.39B | $10.36B | $10.86B | $11.12B |
| 同比增长 | -4.9% | N/A | -1.6% | -0.8% | N/A | 0.2% | 3.0% | 4.9% |
资产负债表
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| 总资产 | $98.73B | $97.09B | $98.50B | $100.36B | $97.32B | $99.04B | $101.23B | $103.02B |
| 总负债 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| 股东权益 | $46.73B | $45.52B | $47.43B | $48.99B | $49.58B | $49.39B | $50.51B | $51.02B |
现金流量表
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| 经营性现金流 | $3.72B | $1.25B | $1.96B | $2.17B | $3.29B | $723.0M | $1.40B | $2.24B |
Other Health Care Companies
A
Agilent Technologies
营收
$1.9B
净利润
$434.0M
TECH
Bio-Techne
营收
$295.9M
净利润
$38.0M
CRL
Charles River Laboratories
营收
$994.2M
净利润
$-276.6M
DHR
Danaher Corporation
营收
$6.1B
净利润
$908.0M
IQV
IQVIA
营收
$4.4B
净利润
$514.0M
MTD
Mettler Toledo
营收
$1.1B
净利润
$285.8M
ABT
Abbott Laboratories
营收
$11.4B
净利润
$1.6B
ABBV
AbbVie
营收
$15.8B
净利润
$186.0M
ALGN
Align Technology
营收
$995.7M
净利润
$56.8M
AMGN
Amgen
营收
$9.9B
净利润
$1.3B